Erythropoietins (Epostim®) during chemoradiotherapy for malignancies in anemic patients

• Autores principales: V. A. Titova (Autor), Yu. M. Kreynina (Autor), A. N. Shipilova (Autor), L. N. Shevchenko (Autor), V. Yu. Petrovsky (Autor), I. V. Ose (Autor), T. F. Skobeleva (Autor), A. V. Akimov (Autor), A. L. Badmayev (Autor)
• Formato: Libro
• Publicado: ABV-press, 2014-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Anemia in female patients with solid neoplasms is corrected to normalize hemoglobin levels, to increase quality of life, and to improve antitumor therapy tolerance. The clinical application of recombinant human erythropoietin preparations has become an important treat- ment step that permits multipl...